It was shown in a study by Wu W et al.19 that the decreased immune function of patients with malignant bone tumors around the knee joint was manifested as a significant decrease in IgA, IgG, IgM, CD3+, CD4+ levels and CD4+/CD8+ values, while a significant increase in CD8+ level. This evidence concerns the gene CD40LG and bone cancer.